nodes	percent_of_prediction	percent_of_DWPC	metapath
Pranlukast—NFKB1—rheumatoid arthritis	0.429	0.765	CbGaD
Pranlukast—TNF—rheumatoid arthritis	0.131	0.235	CbGaD
Pranlukast—ABCC2—Sulfasalazine—rheumatoid arthritis	0.0418	0.188	CbGbCtD
Pranlukast—ABCC2—Cyclosporine—rheumatoid arthritis	0.0317	0.143	CbGbCtD
Pranlukast—CYP2C9—Leflunomide—rheumatoid arthritis	0.0227	0.102	CbGbCtD
Pranlukast—ABCC2—Dexamethasone—rheumatoid arthritis	0.0209	0.0938	CbGbCtD
Pranlukast—ABCC2—Methotrexate—rheumatoid arthritis	0.0168	0.0754	CbGbCtD
Pranlukast—CYP3A4—Ergocalciferol—rheumatoid arthritis	0.0146	0.0657	CbGbCtD
Pranlukast—CYP3A4—Methylprednisolone—rheumatoid arthritis	0.0108	0.0485	CbGbCtD
Pranlukast—CYP2C9—Cyclosporine—rheumatoid arthritis	0.0106	0.0479	CbGbCtD
Pranlukast—CYP3A4—Triamcinolone—rheumatoid arthritis	0.00817	0.0367	CbGbCtD
Pranlukast—IL5—exocrine gland—rheumatoid arthritis	0.00778	0.167	CbGeAlD
Pranlukast—CYP2C9—Dexamethasone—rheumatoid arthritis	0.00701	0.0315	CbGbCtD
Pranlukast—CYP3A4—Betamethasone—rheumatoid arthritis	0.00701	0.0315	CbGbCtD
Pranlukast—CYP3A4—Prednisolone—rheumatoid arthritis	0.00691	0.0311	CbGbCtD
Pranlukast—CYP3A4—Hydrocortisone—rheumatoid arthritis	0.00656	0.0295	CbGbCtD
Pranlukast—CYP3A4—Prednisone—rheumatoid arthritis	0.00653	0.0294	CbGbCtD
Pranlukast—CYP3A4—Cyclosporine—rheumatoid arthritis	0.00619	0.0278	CbGbCtD
Pranlukast—MUC2—exocrine gland—rheumatoid arthritis	0.00598	0.129	CbGeAlD
Pranlukast—CYP3A4—Dexamethasone—rheumatoid arthritis	0.00408	0.0183	CbGbCtD
Pranlukast—IL5—connective tissue—rheumatoid arthritis	0.00356	0.0766	CbGeAlD
Pranlukast—RNASE3—lymphoid tissue—rheumatoid arthritis	0.00287	0.0617	CbGeAlD
Pranlukast—RNASE3—digestive system—rheumatoid arthritis	0.00284	0.0609	CbGeAlD
Pranlukast—MUC2—connective tissue—rheumatoid arthritis	0.00274	0.0589	CbGeAlD
Pranlukast—RNASE3—tendon—rheumatoid arthritis	0.0027	0.058	CbGeAlD
Pranlukast—IL5—lymphoid tissue—rheumatoid arthritis	0.00261	0.056	CbGeAlD
Pranlukast—IL5—digestive system—rheumatoid arthritis	0.00257	0.0553	CbGeAlD
Pranlukast—MUC2—digestive system—rheumatoid arthritis	0.00198	0.0426	CbGeAlD
Pranlukast—NFKB1—parotid gland—rheumatoid arthritis	0.00178	0.0382	CbGeAlD
Pranlukast—NFKB1—saliva-secreting gland—rheumatoid arthritis	0.0017	0.0366	CbGeAlD
Pranlukast—NFKB1—connective tissue—rheumatoid arthritis	0.00156	0.0336	CbGeAlD
Pranlukast—NFKB1—lymphoid tissue—rheumatoid arthritis	0.00114	0.0246	CbGeAlD
Pranlukast—NFKB1—digestive system—rheumatoid arthritis	0.00113	0.0243	CbGeAlD
Pranlukast—CYSLTR1—lymphoid tissue—rheumatoid arthritis	0.00112	0.0241	CbGeAlD
Pranlukast—NFKB1—tendon—rheumatoid arthritis	0.00107	0.0231	CbGeAlD
Pranlukast—ABCC2—digestive system—rheumatoid arthritis	0.000443	0.00953	CbGeAlD
Pranlukast—ABCC2—tendon—rheumatoid arthritis	0.000422	0.00907	CbGeAlD
Pranlukast—CYP2C9—digestive system—rheumatoid arthritis	0.000295	0.00635	CbGeAlD
Pranlukast—CYP3A4—digestive system—rheumatoid arthritis	0.000225	0.00484	CbGeAlD
Pranlukast—IL5—Signaling by GPCR—IL2—rheumatoid arthritis	1.1e-05	6.43e-05	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—VEGFA—rheumatoid arthritis	1.1e-05	6.43e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—C3—rheumatoid arthritis	1.1e-05	6.42e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—RASGRP1—rheumatoid arthritis	1.1e-05	6.42e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—PTPRC—rheumatoid arthritis	1.1e-05	6.41e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—SYK—rheumatoid arthritis	1.1e-05	6.4e-05	CbGpPWpGaD
Pranlukast—IL5—Immune System—CD4—rheumatoid arthritis	1.09e-05	6.38e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL1RN—rheumatoid arthritis	1.09e-05	6.38e-05	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—TP53—rheumatoid arthritis	1.09e-05	6.37e-05	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—TLR4—rheumatoid arthritis	1.08e-05	6.32e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PRKCQ—rheumatoid arthritis	1.08e-05	6.28e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—POMC—rheumatoid arthritis	1.07e-05	6.24e-05	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—IL6—rheumatoid arthritis	1.06e-05	6.2e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—HLA-DPB1—rheumatoid arthritis	1.06e-05	6.2e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—STAT1—rheumatoid arthritis	1.06e-05	6.17e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—UBE2D1—rheumatoid arthritis	1.05e-05	6.15e-05	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—IL6R—rheumatoid arthritis	1.05e-05	6.12e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—CCL2—rheumatoid arthritis	1.05e-05	6.11e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—IL6R—rheumatoid arthritis	1.04e-05	6.09e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CXCL10—rheumatoid arthritis	1.04e-05	6.08e-05	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—HLA-DRB1—rheumatoid arthritis	1.04e-05	6.06e-05	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—IL6ST—rheumatoid arthritis	1.04e-05	6.06e-05	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—IL6—rheumatoid arthritis	1.03e-05	6.05e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—LEP—rheumatoid arthritis	1.02e-05	5.98e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—ADRBK1—rheumatoid arthritis	1.02e-05	5.96e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CD40—rheumatoid arthritis	1.02e-05	5.96e-05	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—IL6—rheumatoid arthritis	1.02e-05	5.96e-05	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—TGFB1—rheumatoid arthritis	1.01e-05	5.9e-05	CbGpPWpGaD
Pranlukast—IL5—Immune System—IL1B—rheumatoid arthritis	1.01e-05	5.9e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CTLA4—rheumatoid arthritis	1.01e-05	5.87e-05	CbGpPWpGaD
Pranlukast—IL5—Immune System—IL2—rheumatoid arthritis	1.01e-05	5.87e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—HMGB1—rheumatoid arthritis	1.01e-05	5.87e-05	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—MMP2—rheumatoid arthritis	1e-05	5.84e-05	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CD80—rheumatoid arthritis	9.99e-06	5.83e-05	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—ICAM1—rheumatoid arthritis	9.96e-06	5.82e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	9.92e-06	5.8e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IRAK1—rheumatoid arthritis	9.91e-06	5.79e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TLE3—rheumatoid arthritis	9.91e-06	5.79e-05	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—TP53—rheumatoid arthritis	9.82e-06	5.74e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CX3CR1—rheumatoid arthritis	9.81e-06	5.73e-05	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—IL6—rheumatoid arthritis	9.81e-06	5.73e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Phase 1 - Functionalization of compounds—POMC—rheumatoid arthritis	9.68e-06	5.66e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—FN1—rheumatoid arthritis	9.65e-06	5.64e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—RASGRP1—rheumatoid arthritis	9.62e-06	5.62e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—IL6ST—rheumatoid arthritis	9.61e-06	5.62e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CD79A—rheumatoid arthritis	9.59e-06	5.6e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—SYK—rheumatoid arthritis	9.59e-06	5.6e-05	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CD80—rheumatoid arthritis	9.59e-06	5.6e-05	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—TYK2—rheumatoid arthritis	9.55e-06	5.58e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—LEP—rheumatoid arthritis	9.53e-06	5.57e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—MMP3—rheumatoid arthritis	9.5e-06	5.55e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—TYK2—rheumatoid arthritis	9.49e-06	5.55e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IL2RB—rheumatoid arthritis	9.45e-06	5.52e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—PRKCQ—rheumatoid arthritis	9.42e-06	5.5e-05	CbGpPWpGaD
Pranlukast—IL5—Immune System—NFKB1—rheumatoid arthritis	9.42e-06	5.5e-05	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—IL6R—rheumatoid arthritis	9.26e-06	5.41e-05	CbGpPWpGaD
Pranlukast—IL5—Immune System—MAPK8—rheumatoid arthritis	9.26e-06	5.41e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CD80—rheumatoid arthritis	9.25e-06	5.41e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—STAT1—rheumatoid arthritis	9.25e-06	5.4e-05	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—TP53—rheumatoid arthritis	9.21e-06	5.38e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—FADS2—rheumatoid arthritis	9.2e-06	5.37e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PTK2—rheumatoid arthritis	9.14e-06	5.34e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—C5—rheumatoid arthritis	9.12e-06	5.33e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—CXCL8—rheumatoid arthritis	9.1e-06	5.32e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NFATC1—rheumatoid arthritis	8.98e-06	5.24e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CCL5—rheumatoid arthritis	8.96e-06	5.24e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—IL6ST—rheumatoid arthritis	8.95e-06	5.23e-05	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—IL6—rheumatoid arthritis	8.95e-06	5.23e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—VCAM1—rheumatoid arthritis	8.88e-06	5.19e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—HLA-DQA1—rheumatoid arthritis	8.85e-06	5.17e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CSF2—rheumatoid arthritis	8.83e-06	5.16e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—POMC—rheumatoid arthritis	8.79e-06	5.14e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—IL2—rheumatoid arthritis	8.7e-06	5.08e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CCL2—rheumatoid arthritis	8.6e-06	5.03e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—IL6R—rheumatoid arthritis	8.58e-06	5.01e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CCR6—rheumatoid arthritis	8.58e-06	5.01e-05	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—TYK2—rheumatoid arthritis	8.43e-06	4.93e-05	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—TP53—rheumatoid arthritis	8.42e-06	4.92e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NCF2—rheumatoid arthritis	8.34e-06	4.88e-05	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—TP53—rheumatoid arthritis	8.31e-06	4.86e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—SPP1—rheumatoid arthritis	8.3e-06	4.85e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—HLA-DQB1—rheumatoid arthritis	8.28e-06	4.84e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—CXCL8—rheumatoid arthritis	8.26e-06	4.83e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—SH2B3—rheumatoid arthritis	8.13e-06	4.75e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TRAF6—rheumatoid arthritis	8.13e-06	4.75e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—GZMB—rheumatoid arthritis	8.08e-06	4.72e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CCR5—rheumatoid arthritis	8.08e-06	4.72e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—PTK2—rheumatoid arthritis	8.01e-06	4.68e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—IL6R—rheumatoid arthritis	7.99e-06	4.67e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IL2RA—rheumatoid arthritis	7.96e-06	4.65e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—IL2—rheumatoid arthritis	7.9e-06	4.61e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—C3—rheumatoid arthritis	7.89e-06	4.61e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL1A—rheumatoid arthritis	7.86e-06	4.59e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL18—rheumatoid arthritis	7.85e-06	4.59e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CXCL2—rheumatoid arthritis	7.85e-06	4.58e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CCL3—rheumatoid arthritis	7.85e-06	4.58e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CD40LG—rheumatoid arthritis	7.82e-06	4.57e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TYK2—rheumatoid arthritis	7.81e-06	4.56e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Biological oxidations—POMC—rheumatoid arthritis	7.8e-06	4.56e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CSF2—rheumatoid arthritis	7.73e-06	4.52e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CD8A—rheumatoid arthritis	7.73e-06	4.52e-05	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—IL6—rheumatoid arthritis	7.71e-06	4.5e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—SAA1—rheumatoid arthritis	7.67e-06	4.48e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—NOS3—rheumatoid arthritis	7.67e-06	4.48e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	7.64e-06	4.47e-05	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CD4—rheumatoid arthritis	7.62e-06	4.45e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—MMP2—rheumatoid arthritis	7.62e-06	4.45e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—AGER—rheumatoid arthritis	7.54e-06	4.41e-05	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—MMP9—rheumatoid arthritis	7.52e-06	4.39e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NCF1—rheumatoid arthritis	7.51e-06	4.39e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—HLA-B—rheumatoid arthritis	7.44e-06	4.35e-05	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—IL6—rheumatoid arthritis	7.35e-06	4.3e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—LEP—rheumatoid arthritis	7.35e-06	4.29e-05	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CD4—rheumatoid arthritis	7.32e-06	4.28e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—TYK2—rheumatoid arthritis	7.27e-06	4.25e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—IL6—rheumatoid arthritis	7.23e-06	4.22e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CD28—rheumatoid arthritis	7.23e-06	4.22e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL2RA—rheumatoid arthritis	6.97e-06	4.07e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—FN1—rheumatoid arthritis	6.93e-06	4.05e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—C3—rheumatoid arthritis	6.91e-06	4.04e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IL6ST—rheumatoid arthritis	6.9e-06	4.03e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—HLA-A—rheumatoid arthritis	6.89e-06	4.03e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—UBE2D1—rheumatoid arthritis	6.8e-06	3.97e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CXCL8—rheumatoid arthritis	6.8e-06	3.97e-05	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—VEGFA—rheumatoid arthritis	6.75e-06	3.94e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—BDKRB2—rheumatoid arthritis	6.67e-06	3.9e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CXCL12—rheumatoid arthritis	6.67e-06	3.9e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CD80—rheumatoid arthritis	6.64e-06	3.88e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ADRBK1—rheumatoid arthritis	6.6e-06	3.85e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CRP—rheumatoid arthritis	6.57e-06	3.84e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—IL2—rheumatoid arthritis	6.5e-06	3.8e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—IL6—rheumatoid arthritis	6.47e-06	3.78e-05	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—MAPK8—rheumatoid arthritis	6.46e-06	3.77e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—POMC—rheumatoid arthritis	6.31e-06	3.69e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—TLR4—rheumatoid arthritis	6.3e-06	3.68e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—HLA-DRB1—rheumatoid arthritis	6.3e-06	3.68e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—RASGRP1—rheumatoid arthritis	6.22e-06	3.63e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—SYK—rheumatoid arthritis	6.2e-06	3.62e-05	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—TGFB1—rheumatoid arthritis	6.2e-06	3.62e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CCL2—rheumatoid arthritis	6.17e-06	3.61e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IL6R—rheumatoid arthritis	6.16e-06	3.6e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—MMP9—rheumatoid arthritis	6.15e-06	3.59e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PLD4—rheumatoid arthritis	6.14e-06	3.59e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—NFKB1—rheumatoid arthritis	6.09e-06	3.56e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PRKCQ—rheumatoid arthritis	6.09e-06	3.56e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—FADS2—rheumatoid arthritis	6.07e-06	3.54e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL6ST—rheumatoid arthritis	6.04e-06	3.53e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—ICAM1—rheumatoid arthritis	6.04e-06	3.53e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—MAPK8—rheumatoid arthritis	5.98e-06	3.5e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—STAT1—rheumatoid arthritis	5.98e-06	3.49e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ACAN—rheumatoid arthritis	5.93e-06	3.46e-05	CbGpPWpGaD
Pranlukast—IL5—Immune System—IL6—rheumatoid arthritis	5.91e-06	3.45e-05	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	5.91e-06	3.45e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CXCL10—rheumatoid arthritis	5.9e-06	3.44e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CD80—rheumatoid arthritis	5.82e-06	3.4e-05	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—TNF—rheumatoid arthritis	5.79e-06	3.38e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—MMP9—rheumatoid arthritis	5.73e-06	3.35e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—NFKB1—rheumatoid arthritis	5.67e-06	3.31e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TYK2—rheumatoid arthritis	5.61e-06	3.28e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—SLC25A12—rheumatoid arthritis	5.57e-06	3.26e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—VEGFA—rheumatoid arthritis	5.52e-06	3.23e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NOS3—rheumatoid arthritis	5.5e-06	3.22e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PTGES—rheumatoid arthritis	5.42e-06	3.17e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GC—rheumatoid arthritis	5.42e-06	3.17e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL6R—rheumatoid arthritis	5.39e-06	3.15e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MMP3—rheumatoid arthritis	5.38e-06	3.14e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PTK2—rheumatoid arthritis	5.18e-06	3.02e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—VEGFA—rheumatoid arthritis	5.14e-06	3e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—POMC—rheumatoid arthritis	5.14e-06	3e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CCL5—rheumatoid arthritis	5.07e-06	2.96e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TGFB1—rheumatoid arthritis	5.07e-06	2.96e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PLB1—rheumatoid arthritis	5.04e-06	2.94e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CSF2—rheumatoid arthritis	5e-06	2.92e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—TYK2—rheumatoid arthritis	4.91e-06	2.87e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CXCL8—rheumatoid arthritis	4.88e-06	2.85e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—TGFB1—rheumatoid arthritis	4.72e-06	2.76e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—SPP1—rheumatoid arthritis	4.7e-06	2.75e-05	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—IL6—rheumatoid arthritis	4.67e-06	2.73e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IL2—rheumatoid arthritis	4.67e-06	2.73e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—IL6—rheumatoid arthritis	4.64e-06	2.71e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IFNG—rheumatoid arthritis	4.6e-06	2.69e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CCR5—rheumatoid arthritis	4.57e-06	2.67e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IL2RA—rheumatoid arthritis	4.51e-06	2.63e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—C3—rheumatoid arthritis	4.47e-06	2.61e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CD4—rheumatoid arthritis	4.44e-06	2.59e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—MED1—rheumatoid arthritis	4.42e-06	2.58e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—MMP9—rheumatoid arthritis	4.42e-06	2.58e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NFKB1—rheumatoid arthritis	4.37e-06	2.55e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—MAPK8—rheumatoid arthritis	4.29e-06	2.51e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TP53—rheumatoid arthritis	4.17e-06	2.44e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—LEP—rheumatoid arthritis	4.16e-06	2.43e-05	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—IL6—rheumatoid arthritis	4.12e-06	2.41e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—B3GNT2—rheumatoid arthritis	4.11e-06	2.4e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ACP5—rheumatoid arthritis	4.11e-06	2.4e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL1B—rheumatoid arthritis	4.1e-06	2.4e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL2—rheumatoid arthritis	4.09e-06	2.39e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PLD4—rheumatoid arthritis	4.05e-06	2.36e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—VEGFA—rheumatoid arthritis	3.97e-06	2.32e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—FN1—rheumatoid arthritis	3.92e-06	2.29e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ACAN—rheumatoid arthritis	3.91e-06	2.28e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IL6ST—rheumatoid arthritis	3.91e-06	2.28e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—IL6—rheumatoid arthritis	3.82e-06	2.23e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—MAPK8—rheumatoid arthritis	3.76e-06	2.2e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CD80—rheumatoid arthritis	3.76e-06	2.2e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—BGN—rheumatoid arthritis	3.7e-06	2.16e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—SLC25A12—rheumatoid arthritis	3.68e-06	2.15e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TGFB1—rheumatoid arthritis	3.64e-06	2.13e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PTGES—rheumatoid arthritis	3.58e-06	2.09e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GC—rheumatoid arthritis	3.58e-06	2.09e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—POMC—rheumatoid arthritis	3.57e-06	2.09e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—IL6—rheumatoid arthritis	3.56e-06	2.08e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CCL2—rheumatoid arthritis	3.5e-06	2.04e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IL6R—rheumatoid arthritis	3.49e-06	2.04e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ALOX5—rheumatoid arthritis	3.4e-06	1.99e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PLB1—rheumatoid arthritis	3.32e-06	1.94e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TYK2—rheumatoid arthritis	3.17e-06	1.85e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NOS3—rheumatoid arthritis	3.12e-06	1.82e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TP53—rheumatoid arthritis	3e-06	1.75e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	2.99e-06	1.75e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—MED1—rheumatoid arthritis	2.91e-06	1.7e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ENO1—rheumatoid arthritis	2.78e-06	1.62e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CXCL8—rheumatoid arthritis	2.76e-06	1.61e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IL6—rheumatoid arthritis	2.74e-06	1.6e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	2.73e-06	1.59e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—B3GNT2—rheumatoid arthritis	2.71e-06	1.58e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ACP5—rheumatoid arthritis	2.71e-06	1.58e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IL2—rheumatoid arthritis	2.64e-06	1.54e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MMP9—rheumatoid arthritis	2.5e-06	1.46e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—BGN—rheumatoid arthritis	2.44e-06	1.43e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MAPK8—rheumatoid arthritis	2.43e-06	1.42e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL6—rheumatoid arthritis	2.4e-06	1.4e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	2.39e-06	1.4e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ALOX5—rheumatoid arthritis	2.25e-06	1.31e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—VEGFA—rheumatoid arthritis	2.25e-06	1.31e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TGFB1—rheumatoid arthritis	2.06e-06	1.2e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CAT—rheumatoid arthritis	2e-06	1.17e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ENO1—rheumatoid arthritis	1.83e-06	1.07e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TP53—rheumatoid arthritis	1.7e-06	9.91e-06	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—MTHFR—rheumatoid arthritis	1.67e-06	9.74e-06	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IL6—rheumatoid arthritis	1.55e-06	9.07e-06	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—POMC—rheumatoid arthritis	1.33e-06	7.79e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CAT—rheumatoid arthritis	1.32e-06	7.7e-06	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ALB—rheumatoid arthritis	1.22e-06	7.1e-06	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—NOS3—rheumatoid arthritis	1.16e-06	6.79e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—MTHFR—rheumatoid arthritis	1.1e-06	6.42e-06	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PTGS2—rheumatoid arthritis	1.06e-06	6.21e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—POMC—rheumatoid arthritis	8.79e-07	5.14e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ALB—rheumatoid arthritis	8.02e-07	4.68e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—NOS3—rheumatoid arthritis	7.67e-07	4.48e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PTGS2—rheumatoid arthritis	7.01e-07	4.1e-06	CbGpPWpGaD
